219873-06-0

Basic information

• Product Name: 4-Cyano-2-fluorobenzyl alcohol
• Synonyms: Benzonitrile, 3-fluoro-4-(hydroxymethyl)- (9CI);3-Fluoro-4-(hydroxymethyl)benzonitrile;4-Cyano-2-fluorobenzyl alcohol;3-Fluoro-4-(hydroxyMethyl)-benzonitrile[4-cyano--2-fluorobenzyl alcohol;3-Fluoro-4-(hydroxymethyl)benzonitrile99+%;Benzonitrile, 3-fluoro-4-(hydroxymethyl)-
• CAS NO: 219873-06-0
• Molecular Formula: C₈H₆FNO
• Molecular Weight: 151.14
• Product Categories: HALIDE;ALDEHYDE
• Mol File: 219873-06-0.mol
• Article Data: 12

Chemical Properties

• Melting Point: 63-68°C
• Boiling Point: 288.8°Cat760mmHg
• Flash Point: 128.5°C
• Appearance: /
• Density: 1.27 g/mL at 25 °C
• Vapor Pressure: 0.00106mmHg at 25°C
• Refractive Index: 1.546
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 13.51±0.10(Predicted)
• CAS DataBase Reference: 4-Cyano-2-fluorobenzyl alcohol(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Cyano-2-fluorobenzyl alcohol(219873-06-0)
• EPA Substance Registry System: 4-Cyano-2-fluorobenzyl alcohol(219873-06-0)

Safety Data

• Hazard Codes: Xi
• Statements: 41
• Safety Statements: 26-39
• WGK Germany: 1
• Hazardous Substances Data: 219873-06-0(Hazardous Substances Data)

Usage

General Description

4-Cyano-2-fluorobenzyl alcohol is a chemical compound with the molecular formula C8H6FNO and a molecular weight of 149.14 g/mol. It is a colorless or pale yellow liquid at room temperature and pressure. 4-Cyano-2-fluorobenzyl alcohol is commonly used as a building block in organic synthesis, particularly in the pharmaceutical and agrochemical industries. It acts as an intermediate in the production of various pharmaceuticals and agrochemicals with potential biological activities. It is also used as a starting material for the synthesis of other organic compounds. Overall, 4-Cyano-2-fluorobenzyl alcohol has important applications in organic chemistry and drug development.

InChI:InChI=1/C8H6FNO/c9-8-3-6(4-10)1-2-7(8)5-11/h1-3,11H,5H2

Upstream product

• 188582-62-9 4-bromo-2-fluorobenzyl alcohol 
• 557-21-1 dicyanozinc 
• 175596-01-7 methyl 4-cyano-2-fluorobenzoate 
• 219873-05-9 C₁₀H₈FNO₂ 
• 64248-62-0 3,4-Difluorobenzonitrile 
• 133059-44-6 4-bromo-3-fluorobenzonitrile 
• 50-00-0 formaldehyd 
• 179232-29-2 methyl 4-bromo-2-fluorobenzoate 
• 105942-10-7 3-fluoro-4-formylbenzonitrile 
• 164149-28-4 4-cyano-2-fluorobenzoic acid 

Downstream Products

• 105942-09-4 4-(bromomethyl)-3-fluorobenzonitrile 
• 105942-10-7 3-fluoro-4-formylbenzonitrile 
• 368426-24-8 3-fluoro-4-(azidomethyl)benzonitrile 
• 1094459-14-9 3-fluoro-N'-hydroxy-4-(hydroxymethyl)benzimidamide 
• 1514888-56-2 1-{2-fluoro-4-[5-(4-isobutylphenyl)-1,2,4-oxadiazol-3-yl]-benzyl}-3-azetidine carboxylic acid 

Relevant articles and documents

Piperidine compound and preparation method and medical application thereof

The invention discloses a piperidine compound shown as a formula (I) and a preparation method and medical application thereof, and particularly relates to a piperidine USP7 inhibitor compound or pharmaceutically acceptable salt or ester or solvate thereof and a preparation method and application of the piperidine USP7 inhibitor compound or pharmaceutically acceptable salt or ester or solvate thereof. The compound provided by the invention can inhibit the activity of USP7 enzyme, has very good selectivity and druggability, and can be used for preparing medicines for preventing or treating tumor diseases or virus infectious diseases.

3-ARYL AND HETEROARYL SUBSTITUTED 5-TRIFLUOROMETHYL OXADIAZOLES AS HISTONE DEACETYLASE 6 (HDAC6) INHIBITORS

The present invention is directed to substituted 5-trifluoromethyl oxadiazole compounds of generic formula (I) or a pharmaceutically acceptable salt thereof. In particular, the invention is directed to a class of aryl and heteroaryl substituted 5-trifluoromethyl oxadiazole compounds of formula I which may be useful as HDAC6 inhibitors for treating cellular proliferative diseases, including cancer, neurodegenerative diseases, such as schizophrenia and stroke, as well as other diseases.

IMMUNE ADJUSTMENT COMPOUND, USE THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

The present invention provides a compound represented by formula I, wherein R is a halogen element or a C1-C6 alkyl group. The compound has S1 P1 receptor agonist activity and selective specificity and has obviously-shortened half-life in-vivo, and therefore the compound is a high-quality second-generation S1P1 receptor agonist. The present invention also provides a use of the compound in preparing medicine for treating diseases or symptoms mediated by an S1P1 receptor, a pharmaceutical composition comprising the compound, and uses of the compound and the pharmaceutical composition in treating diseases or symptoms mediated by the S1 P1 receptor.